Anlon Healthcare (544497) Stock Overview

Manufactures and sells advance pharmaceutical intermediates in India and internationally. More details

544497 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	5/6
Financial Health	3/6
Dividends	0/6

Rewards

Earnings grew by 112.5% over the past year

Risk Analysis

Debt is not well covered by operating cash flow

Shares are highly illiquid

High level of non-cash earnings

Does not have a meaningful market cap (₹7B)

544497 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Hoth Therapeutics

100% Patient Improvement in trial puts this $16M Biotech on the radar

Key Takeaways Hoth is a clinical-stage biotech with a diversified pipeline across oncology, neurology, and inflammation. Lead drug HT-001 targets cancer treatment related rashes, a multi-hundred-million-dollar niche where no approved therapies exist.

132

US$5.3

70.2% undervalued

Jolt_Communications Fair Value

Revenue growth

N/A

Profit Margin

30%

Future PE

20x

Share price in 2030

US$0

Anlon Healthcare Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Anlon Healthcare
Historical stock prices
Current Share Price	₹128.00
52 Week High	₹147.80
52 Week Low	₹86.98
Beta	0
1 Month Change	39.21%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	39.65%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	544497	IN Pharmaceuticals	IN Market
7D	-0.02%	1.4%	1.5%
1Y	n/a	-7.2%	-4.7%

Return vs Industry: Insufficient data to determine how 544497 performed against the Indian Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 544497 performed against the Indian Market.

Price Volatility

Is 544497's price volatile compared to industry and market?
544497 volatility
544497 Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	5.0%
Market Average Movement	5.2%
10% most volatile stocks in IN Market	8.3%
10% least volatile stocks in IN Market	3.2%

Stable Share Price: 544497's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: Insufficient data to determine 544497's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2013	117	Punitkumar Rasadia	www.anlon.in

Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumatic therapeutics areas.

Anlon Healthcare Limited Fundamentals Summary

How do Anlon Healthcare's earnings and revenue compare to its market cap?
544497 fundamental statistics
Market cap	₹6.74b
Earnings (TTM)	₹205.18m
Revenue (TTM)	₹1.20b

32.9x

P/E Ratio

5.6x

P/S Ratio

Is 544497 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
544497 income statement (TTM)
Revenue	₹1.20b
Cost of Revenue	₹752.26m
Gross Profit	₹451.07m
Other Expenses	₹245.90m
Earnings	₹205.18m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	3.86
Gross Margin	37.49%
Net Profit Margin	17.05%
Debt/Equity Ratio	82.8%

How did 544497 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/10/05 08:56
End of Day Share Price	2025/10/03 00:00
Earnings	2025/03/31
Annual Earnings	2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Anlon Healthcare Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.